The Only Complete Online Marketing Firm
Wednesday, April 22, 2015
Increasing Tysabri Dosing Interval May Cut PML Risk
(MedPage Today) -- No sacrifice of efficacy seen in retrospective analysis.
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment